GRIK4
Glutamate receptor ionotropic, kainate 4
Also known as: GluK4, GRIK, GRIK4_HUMAN, KA1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16099
- Gene
- GRIK4
- Ensembl
- ENSG00000149403
- Chromosome
- 11
- Canonical length
- 956 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that belongs to the glutamate-gated ionic channel family. Glutamate functions as the major excitatory neurotransmitter in the central nervous system through activation of ligand-gated ion channels and G protein-coupled membrane receptors. The protein encoded by this gene forms functional heteromeric kainate-preferring ionic channels with the subunits encoded by related gene family members. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
956 residues, UniProt reviewed canonical sequence.
>Q16099|GRIK4
1 MPRVSAPLVL LPAWLVMVAC SPHSLRIAAI LDDPMECSRG ERLSITLAKN RINRAPERLG
61 KAKVEVDIFE LLRDSEYETA ETMCQILPKG VVAVLGPSSS PASSSIISNI CGEKEVPHFK
121 VAPEEFVKFQ FQRFTTLNLH PSNTDISVAV AGILNFFNCT TACLICAKAE CLLNLEKLLR
181 QFLISKDTLS VRMLDDTRDP TPLLKEIRDD KTATIIIHAN ASMSHTILLK AAELGMVSAY
241 YTYIFTNLEF SLQRMDSLVD DRVNILGFSI FNQSHAFFQE FAQSLNQSWQ ENCDHVPFTG
301 PALSSALLFD AVYAVVTAVQ ELNRSQEIGV KPLSCGSAQI WQHGTSLMNY LRMVELEGLT
361 GHIEFNSKGQ RSNYALKILQ FTRNGFRQIG QWHVAEGLSM DSHLYASNIS DTLFNTTLVV
421 TTILENPYLM LKGNHQEMEG NDRYEGFCVD MLKELAEILR FNYKIRLVGD GVYGVPEANG
481 TWTGMVGELI ARKADLAVAG LTITAEREKV IDFSKPFMTL GISILYRVHM GRKPGYFSFL
541 DPFSPGVWLF MLLAYLAVSC VLFLVARLTP YEWYSPHPCA QGRCNLLVNQ YSLGNSLWFP
601 VGGFMQQGST IAPRALSTRC VSGVWWAFTL IIISSYTANL AAFLTVQRMD VPIESVDDLA
661 DQTAIEYGTI HGGSSMTFFQ NSRYQTYQRM WNYMYSKQPS VFVKSTEEGI ARVLNSNYAF
721 LLESTMNEYY RQRNCNLTQI GGLLDTKGYG IGMPVGSVFR DEFDLAILQL QENNRLEILK
781 RKWWEGGKCP KEEDHRAKGL GMENIGGIFV VLICGLIVAI FMAMLEFLWT LRHSEATEVS
841 VCQEMVTELR SIILCQDSIH PRRRRAAVPP PRPPIPEERR PRGTATLSNG KLCGAGEPDQ
901 LAQRLAQEAA LVARGCTHIR VCPECRRFQG LRARPSPARS EESLEWEKTT NSSEPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRIK4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 6.3 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 6.3 nTPM
- basal ganglia: 5 nTPM
- hippocampal formation: 4.8 nTPM
- hypothalamus: 4.3 nTPM
- spinal cord: 3.8 nTPM
- midbrain: 3.5 nTPM
Single-cell type
- bergmann glia: 398 nCPM
- ependymal cells: 321 nCPM
- oligodendrocyte progenitor cells: 286 nCPM
- cone photoreceptor cells: 226 nCPM
- other brain neurons: 148 nCPM
- gonadotrophs: 148 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 24 nTPM
- hypothalamus: 23 nTPM
- pons: 18 nTPM
- amygdala: 16 nTPM
- medulla oblongata: 16 nTPM
- basal ganglia: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 2.04
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- glutamate receptor signaling pathway
- modulation of chemical synaptic transmission
- synaptic transmission, glutamatergic
Molecular functions
- kainate selective glutamate receptor activity
- ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ionotropic glutamate receptor, C-terminal
- Ionotropic glutamate receptor, metazoa
- Receptor, ligand binding region
- Ionotropic glutamate receptor
- Ionotropic glutamate receptor, L-glutamate and glycine-binding domain
- Periplasmic binding protein-like I
- Ligand-gated ion channel
- Receptor family ligand binding region
- Ligated ion channel L-glutamate- and glycine-binding site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRIK4 as an antibody target. Whether an autoantibody or antibody against GRIK4 could matter depends on whether native GRIK4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRIK4 is annotated at the cell surface, where native GRIK4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRIK4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...